(Q37306567)

19 August 2017

1 reference

title

Basal-like subtype and BRCA1 dysfunction in breast cancers (English)

1 reference

19 August 2017

Yasuo Miyoshi

1

1 reference

PubMed ID

18946749

19 August 2017

Keiko Murase

series ordinal

2

1 reference

PubMed ID

18946749

19 August 2017

Koushi Oh

series ordinal

3

1 reference

19 August 2017

23 October 2008

1 reference

International Journal of Clinical Oncology

19 August 2017

1 reference

19 August 2017

13

1 reference

19 August 2017

395-400

1 reference

19 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s10147-008-0831-x

19 August 2017

0 references

cites work

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10147-008-0831-X

BRCA1 downregulation leads to premature inactivation of spindle checkpoint and confers paclitaxel resistance

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10147-008-0831-X

Dominant-negative activity of a Brca1 truncation mutant: effects on proliferation, tumorigenicity in vivo, and chemosensitivity in a mouse ovarian cancer cell line.

21 January 2018

1 reference

12 December 2020

The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells.

1 reference

12 December 2020

Hallmarks of 'BRCAness' in sporadic cancers

1 reference

12 December 2020

The role of BRCA1 in the cellular response to chemotherapy

1 reference

12 December 2020

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

1 reference

12 December 2020

Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data

1 reference

12 December 2020

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients

1 reference

12 December 2020

Molecular portraits of human breast tumours

1 reference

12 December 2020

Triple-negative breast cancer: therapeutic options

1 reference

12 December 2020

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

1 reference

12 December 2020

BRCA1--a good predictive marker of drug sensitivity in breast cancer treatment?

1 reference

12 December 2020

Basal-like breast carcinomas: clinical outcome and response to chemotherapy

1 reference

12 December 2020

Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis

1 reference

12 December 2020

Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells.

1 reference

12 December 2020

Loss of BRCA1 expression may predict shorter time-to-progression in metastatic breast cancer patients treated with taxanes

1 reference

12 December 2020

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

12 December 2020

Basal-like breast cancer and the BRCA1 phenotype

1 reference

12 December 2020

Negative Regulation of BRCA1 Gene Expression by HMGA1 Proteins Accounts for the Reduced BRCA1 Protein Levels in Sporadic Breast Carcinoma

1 reference

12 December 2020

Low nuclear grade but not cell proliferation predictive of pathological complete response to docetaxel in human breast cancers

1 reference

12 December 2020

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer

1 reference

12 December 2020

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

1 reference

12 December 2020

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

1 reference

12 December 2020

Multiple pathways of recombination define cellular responses to cisplatin

1 reference

12 December 2020

BRCA1 regulates human mammary stem/progenitor cell fate

1 reference

12 December 2020

Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers

1 reference

12 December 2020

Topoisomerase IIalpha-positive and BRCA1-negative phenotype: association with favorable response to epirubicin-based regimens for human breast cancers

1 reference

12 December 2020

Triple negative tumours: a critical review

1 reference

12 December 2020

1 reference

12 December 2020

Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition.

1 reference

12 December 2020

Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway

1 reference

12 December 2020

BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis

1 reference

12 December 2020

Overexpression and amplification of Aurora-A in hepatocellular carcinoma

1 reference

12 December 2020

Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation

1 reference

12 December 2020

Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer

1 reference

12 December 2020

Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma

1 reference

12 December 2020

Primary resistance to docetaxel-based chemotherapy in metastatic breast cancer patients correlates with a high frequency of BRCA1 mutations

1 reference

12 December 2020

[Effect of a new anticancer drug, docetaxel (RP56976), on human leukemia cell lines].

1 reference

12 December 2020

Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics

1 reference

12 December 2020

Comparative effects of taxol and Taxotere on two different human carcinoma cell lines

1 reference

12 December 2020

Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells

1 reference

12 December 2020

Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response

1 reference

12 December 2020

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

1 reference

12 December 2020

BRCA1 dysfunction in sporadic basal-like breast cancer

1 reference

12 December 2020

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

1 reference

12 December 2020

RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells.

1 reference

12 December 2020

DNA topoisomerase I and II as targets for rational design of new anticancer drugs

1 reference

12 December 2020

Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer.

1 reference

12 December 2020

Nucleotide excision repair in mammalian cells

1 reference

12 December 2020

Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis.

1 reference

12 December 2020

Deconstructing the molecular portrait of basal-like breast cancer

1 reference

12 December 2020

10.1007/S10147-008-0831-X

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18946749